Concourse Financial Group Securities, Inc. Autolus Therapeutics PLC Transaction History

Concourse Financial Group Securities, Inc.

$1.67 Billion
Q4 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$2.18 - $4.8 $0 - $0	0 New	0 $0
Q3 2024 Oct 10, 2024	BUY	$3.38 - $4.69 $0 - $0	0 New	0 $0
Q2 2024 Jul 23, 2024	BUY	$3.33 - $5.68 $0 - $0	0 New	0 $0
Q1 2024 Apr 30, 2024	BUY	$5.39 - $7.29 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$2.13 - $6.63 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$2.32 - $3.36 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	BUY	$2.32 - $3.36 $0 - $0	0 New	0 $0
Q2 2023 Aug 10, 2023	BUY	$1.64 - $3.21 $0 - $0	0 New	0 $0
Q1 2023 May 15, 2023	BUY	$1.75 - $2.25 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$1.74 - $3.27 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$2.04 - $3.76 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$2.04 - $4.68 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	SELL	$3.52 - $5.46 $3,520 - $5,460	-1,000 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$8.13 - $12.79 $4,065 - $6,395	-500 Reduced 33.33%	1,000 $9,000
Q3 2020 Nov 13, 2020	BUY	$11.64 - $16.3 $17,460 - $24,450	1,500 New	1,500 $17,000
Q2 2020 Aug 13, 2020	BUY	$5.38 - $16.14 $0 - $0	0 New	0 $0
Q1 2020 May 13, 2020	BUY	$4.2 - $13.0 $0 - $0	0 New	0 $0
Q4 2019 Feb 14, 2020	BUY	$11.13 - $16.28 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	BUY	$9.79 - $16.72 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	BUY	$15.1 - $31.25 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	BUY	$24.38 - $34.71 $0 - $0	0 New	0 $0
Q4 2018 Feb 14, 2019	BUY	$24.21 - $48.01 $0 - $0	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	$20.86 - $33.33 $0 - $0	0 New	0 $0

Others Institutions Holding AUTL

# of Institutions

114

Shares Held

160M

Call Options Held

2.8K

Put Options Held

89.9K

Wellington Management Group LLP Boston, MA

25.3M
Shares

$49.2 Million
0.01% of portfolio
Blackstone Inc New York, NY

20.5M
Shares

$39.7 Million
0.24% of portfolio
Syncona Portfolio LTD Guernsey, Channel Islands, X0

16.6M
Shares

$32.3 Million
73.83% of portfolio
Deep Track Capital, LP Greenwich, CT

14.2M
Shares

$27.6 Million
1.47% of portfolio
Avoro Capital Advisors LLC New York, NY

9.91M
Shares

$19.2 Million
0.34% of portfolio

View Full List

About Autolus Therapeutics plc

Ticker AUTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,909,800
Market Cap $176M
Description
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...

More about AUTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account